Drug Shortage Report for DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP

Last updated on 2021-12-09 History
Report ID 146385
Drug Identification Number 00761850
Brand name DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP
Common or Proper name Dopamine
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) DEXTROSE DOPAMINE HYDROCHLORIDE
Strength(s) 50MG .8MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250mL (18 bags per case)
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-09-30
Actual start date 2021-09-30
Estimated end date 2021-12-08
Actual end date 2021-12-08
Shortage status Resolved
Updated date 2021-12-09
Company comments Baxter products Dopamine Hydrochloride and 5% Dextrose USP – 400mg/250mL bags (DIN 00761826) and 800mg/250mL bags (DIN 00761834) are available as alternatives if they align with clinical practice.
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2021-12-09 English Compare
v15 2021-12-08 French Compare
v14 2021-12-08 English Compare
v13 2021-12-06 French Compare
v12 2021-12-06 English Compare
v11 2021-11-26 French Compare
v10 2021-11-26 English Compare
v9 2021-11-18 French Compare
v8 2021-11-18 English Compare
v7 2021-11-15 French Compare
v6 2021-11-15 English Compare
v5 2021-11-11 French Compare
v4 2021-11-11 English Compare
v3 2021-10-01 English Compare
v2 2021-09-30 French Compare
v1 2021-09-30 English Compare

Showing 1 to 16 of 16